Even when cancer was found in the bladder or ureter, the urine test for cancer cells came back negative every time—so it didn’t help catch the cancer early.
Scientific Claim
Urine cytology was negative for malignancy in all 20 patients with high-grade microscopic hematuria, despite four cases of confirmed urothelial cancer, indicating that urine cytology lacks sensitivity for detecting early-stage urothelial malignancy in young men.
Original Statement
“Urine cytology was free in all of them... Pathology showed positive urine cytology and CIS of the ureter [in one case]... All random biopsies taken from the cases were free of malignancy.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The claim accurately reports a null finding in a small cohort without implying universal applicability. The language appropriately reflects observational data.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Prospective Cohort StudyLevel 2bThe sensitivity and specificity of urine cytology for detecting urothelial malignancy in young men with high-grade microscopic hematuria and normal imaging.
The sensitivity and specificity of urine cytology for detecting urothelial malignancy in young men with high-grade microscopic hematuria and normal imaging.
What This Would Prove
The sensitivity and specificity of urine cytology for detecting urothelial malignancy in young men with high-grade microscopic hematuria and normal imaging.
Ideal Study Design
A prospective cohort of 300 men under 40 with ≥25 RBC/HPF, normal CT, and no infection, all undergoing cystoscopy/uretroscopy and concurrent urine cytology; primary outcome: sensitivity and specificity of cytology for malignancy.
Limitation: Cannot determine if cytology adds value beyond imaging or scope.
Systematic Review & Meta-AnalysisLevel 1aThe pooled diagnostic accuracy of urine cytology in young adults (<40) with microscopic hematuria and normal imaging.
The pooled diagnostic accuracy of urine cytology in young adults (<40) with microscopic hematuria and normal imaging.
What This Would Prove
The pooled diagnostic accuracy of urine cytology in young adults (<40) with microscopic hematuria and normal imaging.
Ideal Study Design
A systematic review and meta-analysis of all prospective studies evaluating urine cytology in patients under 40 with microscopic hematuria and normal imaging; primary outcomes: sensitivity, specificity, PPV, NPV for urothelial cancer.
Limitation: May be confounded by variations in cytology interpretation and sample collection.
Cross-Sectional StudyLevel 3cThe proportion of cytology-negative cases among young men with confirmed urothelial malignancy and microscopic hematuria.
The proportion of cytology-negative cases among young men with confirmed urothelial malignancy and microscopic hematuria.
What This Would Prove
The proportion of cytology-negative cases among young men with confirmed urothelial malignancy and microscopic hematuria.
Ideal Study Design
A cross-sectional study of 100 young men (<40) with confirmed urothelial cancer and ≥25 RBC/HPF, assessing prior urine cytology results for sensitivity.
Limitation: Cannot establish predictive value or timing of cytology relative to diagnosis.
Evidence from Studies
Supporting (1)
High-grade microscopic hematuria in adult men can predict urothelial malignancy.
The study found that some young men had bladder cancer even though their urine tests didn't show it, meaning the urine test missed the cancer — so it's not reliable for catching early bladder cancer.